Jarvis G A, Griffiss J M
Department of Laboratory Medicine, University of California, San Francisco.
J Immunol. 1991 Sep 15;147(6):1962-7.
We have recently shown that human IgA1 can initiate lysis of group C Neisseria meningitidis via the classical C pathway when bound to specific outer membrane proteins, but that IgA1 can also function as a blocking antibody when bound to the polysaccharide capsule of meningococci. In this report, we further characterized IgA1 blockade by examining the effect of IgA1 on IgG-initiated immune lysis of group C meningococci. We purified IgG and monomeric IgA1 from either convalescent group C meningococcal case sera or tetravalent (A, C, Y, W135) polysaccharide vaccinate sera. In the absence of IgA1, IgG initiated complete lysis (greater than 99%) of strains 118V (C:P3,4:L2,4) 126E (C:P3:L1,8), and 35E (C:P5:L2). Addition of IgA1 to the bactericidal reaction mixture completely blocked the lytic function of IgG. Removal of the Fc portion of IgA1 with either pepsin or IgA1 protease did not affect blockade. Both the F(ab')2 and Fab derivatives of IgA1 blocked lysis quantitatively as well as intact IgA1. The Fc fragment produced by IgA1 protease cleavage neither increased nor decreased Fab-mediated blockade. IgA1 and its Fab and F(ab')2 fragments blocked IgG-initiated lysis via either the classical pathway in factor B-depleted and in properdin-deficient serum, the alternative pathway in MgEGTA-chelated serum, or both pathways combined. Absorption of the IgA1 and IgG with alum-bound group C polysaccharide completely removed blocking and lytic activity, respectively, indicating that both the blocking IgA1 and the lytic IgG were specific for the group C capsule. Blocking by IgA1 was a linear function of the polysaccharide Ag-binding capacity (ABC) ratio of blocking IgA1 to lytic IgG. Complete blockade was observed at an ABC ratio of 5.5. At ABC ratios of 3.3 and 4.4, IgA1 affected significant blockade whether added previous to, concurrent with, or subsequent to sensitization of the organisms with IgG. With the use of a C polysaccharide ELISA, we found that the binding of IgA1 to the group C capsule in the presence of IgG exhibited positive cooperativity and therefore that blockade was independent of the ability of IgA1 to directly compete with IgG for binding to epitopes within the group C capsule. We conclude that IgA1, when bound to the group C polysaccharide capsule, can block IgG-initiated lysis of group C meningococci through either the classical or the alternative pathway before or after the organism is exposed to IgG, and that blockade is an Fc-independent event.
我们最近发现,人IgA1与特定外膜蛋白结合时可通过经典补体途径引发C群脑膜炎奈瑟菌的溶解,但IgA1与脑膜炎球菌多糖荚膜结合时也可作为封闭抗体发挥作用。在本报告中,我们通过研究IgA1对IgG引发的C群脑膜炎球菌免疫溶解的影响,进一步对IgA1的封闭作用进行了表征。我们从恢复期C群脑膜炎球菌病例血清或四价(A、C、Y、W135)多糖疫苗接种血清中纯化了IgG和单体IgA1。在没有IgA1的情况下,IgG可引发118V株(C:P3,4:L2,4)、126E株(C:P3:L1,8)和35E株(C:P5:L2)的完全溶解(大于99%)。向杀菌反应混合物中添加IgA1可完全阻断IgG的溶解功能。用胃蛋白酶或IgA1蛋白酶去除IgA1的Fc部分并不影响封闭作用。IgA1的F(ab')2和Fab衍生物在定量上与完整的IgA1一样可阻断溶解。IgA1蛋白酶切割产生的Fc片段既不增加也不减少Fab介导的封闭作用。IgA1及其Fab和F(ab')2片段可通过B因子缺陷和备解素缺陷血清中的经典途径、MgEGTA螯合血清中的替代途径或两者结合的途径阻断IgG引发的溶解。用明矾结合的C群多糖吸收IgA1和IgG分别完全消除了封闭活性和溶解活性,表明封闭性IgA1和溶解性IgG均对C群荚膜具有特异性。IgA1的封闭作用是封闭性IgA1与溶解性IgG的多糖抗原结合能力(ABC)比值的线性函数。在ABC比值为5.5时观察到完全封闭。在ABC比值为3.3和4.4时,无论在IgG致敏之前、同时或之后添加IgA1,均观察到显著的封闭作用。通过使用C多糖ELISA,我们发现IgA1在IgG存在下与C群荚膜的结合表现出正协同性,因此封闭作用与IgA1直接与IgG竞争结合C群荚膜内表位的能力无关。我们得出结论,IgA1与C群多糖荚膜结合时,可在细菌接触IgG之前或之后通过经典途径或替代途径阻断IgG引发的C群脑膜炎球菌溶解,且封闭作用是一个不依赖Fc的事件。